Momenta Pharmaceuticals, Inc. to Present at the UBS Global Life Sciences Conference and Pharmaceutical Strategic Alliances Conference

CAMBRIDGE, Mass., Sept. 19, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced its participation in two upcoming September conferences.